HIGH-THROUGHPUT CHEMICAL SCREEN OF PATIENT DERIVED GBM TUMOR INITIALIZING CELLS PI: Greg D. Foltz, M.D. Director, The Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Medical Center